文献速递临床微生物分子诊断

Accelerate Pheno系统用于革兰阴性血流感染血培养快速鉴定与药敏评估

Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.
PubMed 文献 · J Clin Microbiol · 2017-04-26

本研究纳入115例革兰阴性菌血流感染发作,评估Accelerate Pheno系统直接从阳性血培养进行鉴定与药敏试验的性能。系统对88.7%发作正确鉴定,覆盖面板菌株鉴定率97.1%,药敏总体分类一致率96.4%,并显著缩短鉴定与药敏报告时间。

要点

  • Accelerate Pheno系统约7小时内直接从阳性血培养完成鉴定与药敏。
  • 覆盖面板菌株鉴定正确率97.1%,药敏总体分类一致率96.4%。
  • 相比培养法,鉴定报告时间缩短27.49小时,药敏缩短40.39小时。

核心结论

  • Accelerate Pheno系统为革兰阴性血流感染血培养诊断提供快速可靠结果,并显著改善周转时间。

研究设计与样本

  • 研究纳入115例革兰阴性菌血流感染发作,将Accelerate Pheno系统与常规培养法进行比较。

主要发现

  • 系统正确鉴定88.7%(102/115)的发作,覆盖面板菌株鉴定率97.1%(102/105)。
  • 在系统鉴定出革兰阴性病原体的104份样本中,91.3%(95/104)生成药敏结果。
  • 药敏总体分类一致率96.4%,次要差异1.4%,重大差异2.3%,极重大差异1.0%。
  • 正确检测产超广谱β-内酰胺酶大肠埃希菌(n=7)和多重耐药铜绿假单胞菌(n=3)对头孢曲松、哌拉西林-他唑巴坦和碳青霉烯类的耐药性。
  • 相比培养法,鉴定报告时间缩短27.49小时(P < 0.0001),药敏报告时间缩短40.39小时(P < 0.0001)。

临床怎么用

  • 可用于革兰阴性血流感染阳性血培养的快速鉴定与药敏,辅助及时调整和降阶梯治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bloodstream infections (BSI) are an important cause of morbidity and mortality. Increasing rates of antimicrobial-resistant pathogens limit treatment options, prompting an empirical use of broad-range antibiotics. Fast and reliable diagnostic tools are needed to provide adequate therapy in a timely manner and to enable a de-escalation of treatment. The Accelerate Pheno system (Accelerate Diagnostics, USA) is a fully automated test system that performs both identification and antimicrobial susceptibility testing (AST) directly from positive blood cultures within approximately 7 h. In total, 115 episodes of BSI with Gram-negative bacteria were included in our study and compared to conventional culture-based methods. The Accelerate Pheno system correctly identified 88.7% (102 of 115) of all BSI episodes and 97.1% (102 of 105) of isolates that are covered by the system's identification panel. The Accelerate Pheno system generated an AST result for 91.3% (95 of 104) samples in which the Accelerate Pheno system identified a Gram-negative pathogen. The overall category agreement between the Accelerate Pheno system and culture-based AST was 96.4%, the rates for minor discrepancies 1.4%, major discrepancies 2.3%, and very major discrepancies 1.0%. Of note, ceftriaxone, piperacillin-tazobactam, and carbapenem resistance was correctly detected in blood culture specimens with extended-spectrum beta-lactamase-producing Escherichia coli (n = 7) and multidrug-resistant Pseudomonas aeruginosa (n = 3) strains. The utilization of the Accelerate Pheno system reduced the time to result for identification by 27.49 h (P < 0.0001) and for AST by 40.39 h (P < 0.0001) compared to culture-based methods in our laboratory setting. In conclusion, the Accelerate Pheno system provided fast, reliable results while significantly improving turnaround time in blood culture diagnostics of Gram-negative BSI.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Marschal M, Bachmaier J, Autenrieth I, et al. Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens. J Clin Microbiol. 2017. PMID: 28446572. doi:10.1128/JCM.00181-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。